NCT03043326View on ClinicalTrials.gov

Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 23, 2017

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2022

Conditions
HIV Prevention
Interventions
DRUG

Tenofovir Disoproxil Fumarate and Emtricitabine

This is an observational study. Pre-exposure Prophylaxis with TDF/3TC will be distributed to all participants elegible to receive PrEP.

Trial Locations (5)

16000

RECRUITING

Asociacion Civil Selva amazonica, Iquitos

Lima 01

RECRUITING

Asociacion Via Libre, Lima

Lima 04

RECRUITING

Asociacion Civil Impacta Salud y Educacion- Barranco CRS, Lima

RECRUITING

Epicentro, Lima

Lima 32

RECRUITING

Asociación Civil Impacta Salud y Educación-San Miguel CRS, Lima

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Asociación Civil Impacta Salud y Educación, Peru

OTHER